Panasonic Corp <6752>: 1366.5 yen (+128.5 yen)

Significant rebound. The day before, it announced the financial results for the second quarter, with an operating profit of 132.3 billion yen for the July-September period, a 29.1% increase from the same period last year, significantly surpassing market expectations by nearly 25 billion yen. The full-year forecast remains at 380 billion yen, a 5.3% increase from the previous year, and as there was a high possibility of downward revision in the market, positive views are prevailing. The company's energy business is performing better than expected, driven by expansion in the AI data center sector.

Mitsubishi Electric Corp <6503>: 2746.5 yen (+359 yen)

Significant rebound. The day before, it announced the financial results for the second quarter, with an operating profit of 118 billion yen for the July-September period, a 57.7% increase from the same period last year, exceeding market expectations by around 40 billion yen. The full-year forecast remains at 400 billion yen, maintaining a 21.8% increase from the previous year. However, concerns about a downward revision still exist, hence the positive impact of the exceeding profit forecasts. The company's air conditioning and consumer electronics profitability have improved more than anticipated, and the previously concerning FA systems are also showing significant profit margin improvements.

Laser Tech Corp <6920>: 19950 yen (-3525 yen)

Significant decline. The day before, it announced the financial results for the first quarter, with an operating profit of 15.9 billion yen, a 54.9% increase from the same period last year. However, market expectations are nearly 10 billion yen lower. The full-year forecast of 104 billion yen, with a 27.8% increase from the previous year, remains unchanged. While concerns related to order cancellations or postponements following ASML's downward revision of its outlook have not materialized, there is a slight slowdown in inquiries such as ACTIS and MATRICS. It is noted that the company has discontinued disclosing quarterly order amounts and order backlogs starting from this fiscal year.

Sosei Next Corp <6526>: 2530.5 yen (-391.5 yen)

Significant continued decline. The day before, it announced the financial results for the second quarter, with an operating profit of 5.29 billion yen for the July-September period, a 38.2% decrease from the same period last year and a 48.5% decrease from the previous quarter. The full-year forecast remains unchanged at 27 billion yen, with a 24.0% decrease from the previous year. However, in real terms excluding exchange rate effects, it is expected to fall by about 10% compared to the initial forecast. Sales are declining in the data center and network fields compared to the initial expectations, with a mainly lower performance in the Chinese regional market.

Fujitsu <6702>: ¥2737 (-¥226)

Significant decline. The company announced its second-quarter financial results the previous day, with operating profit for the July-September period at 35 billion yen, a decrease of 24.6% year-on-year, falling below the market's financial estimates of around 60 billion yen. The full-year estimate has been downwardly revised from the previous 330 billion yen to 310 billion yen, an increase of 93.4% compared to the previous year. Early retirement recruitment costs of approximately 20 billion yen were recorded in the second quarter, which is considered a factor contributing to the lower-than-expected performance. However, there seems to be a prevailing view of slight disappointment. It appears that orders and sales in the regions have struggled to grow as anticipated.

Shinbio Pharmaceuticals <4582>: ¥232 (-¥7)

Continued decline. After the trading on the 31st, the financial results for the third quarter of the fiscal year ending December 24 were announced, triggering selling pressure. Operating loss expanded to ¥2.791 billion (compared to operating loss of ¥0.283 billion in the same period last year), and ordinary loss widened to ¥2.759 billion (compared to ordinary loss of ¥0.156 billion in the same period last year). Research and development expenses amounted to ¥2.492 billion (an increase of 36.69% from the same period last year), bringing the total including other selling and general administrative expenses to ¥4.235 billion (a 12.7% increase from the same period last year).

McLeod <7687>: ¥429 (+¥32)

Continued rise. After the trading on the 31st, upward revision of the full-year earnings forecast for the fiscal year ending March 25, announcement of surplus dividend (interim dividend), and revision of dividend forecast have been made, considered as positive factors. The revenue forecast has been revised from ¥6.55 billion to ¥6.85 billion (an increase of 4.6%), and the operating profit forecast has been revised from ¥0.335 billion to ¥0.365 billion (an increase of 9.0%). Additionally, the interim dividend has been increased by ¥0.40 per share from the recent forecast to ¥3.80, and the year-end dividend has been increased by ¥0.20 per share to ¥3.70. As a result, the expected annual dividend per share including the interim dividend is ¥7.50.

JayTech <2479>: ¥231 (+¥4)

Continued rise. For the second quarter of the fiscal year ending March 25, the revenue was ¥1.647 billion (an increase of 1.4% from the same period last year), and the operating profit was ¥0.098 billion (an increase of 50.1%). In the manufacturing sector, a key customer of stem inc, the demand for "technologists" with advanced technology and human skills in the main technology intellectual property leasing business continues to be stable. Furthermore, through strengthened collaboration between departments, high evaluations have been received from repeat customers, leading to further strengthening of the revenue base and cost reduction through business efficiency improvements. As a result, profit performance has been strong, with an increase in profits compared to the same period last year at all levels.